PD-1/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic review and meta-analysis of randomized clinical trials

Peer Review reports

Original Submission
6 Sep 2023	Submitted	Original manuscript
2 Oct 2023	Reviewed	Reviewer Report
22 Oct 2023	Reviewed	Reviewer Report - Reza Alizadeh-Navaei
23 Oct 2023	Reviewed	Reviewer Report
29 Oct 2023	Author responded	Author comments - Francisco Cezar Aquino de Moraes
Resubmission - Version 2
29 Oct 2023	Submitted	Manuscript version 2
31 Oct 2023	Author responded	Author comments - Francisco Cezar Aquino de Moraes
Resubmission - Version 3
31 Oct 2023	Submitted	Manuscript version 3
7 Nov 2023	Reviewed	Reviewer Report
16 Nov 2023	Reviewed	Reviewer Report - Reza Alizadeh-Navaei
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
18 Nov 2023	Editorially accepted
29 Nov 2023	Article published	10.1186/s12885-023-11654-z

Back to article page